Leerink initiates Entera Bio coverage with Outperform and $9 target
Leerink Partners initiated coverage on Entera Bio with an Outperform rating and a $9.00 price target. The target implies 197.0% upside versus the Sep 17 close of $3.03.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.